Interest in peptide therapy has grown rapidly as patients look beyond traditional weight-loss strategies and begin asking more detailed questions about metabolism, body composition, visceral fat, mitochondrial health, and healthy aging.

Three peptides frequently discussed in this space are AOD-9604, MOTS-c, and tesamorelin.

Although these peptides are often grouped together, they are very different compounds.

AOD-9604 has been investigated primarily for its potential effects on fat metabolism. MOTS-c is an investigational mitochondrial-derived peptide being studied for its role in cellular energy and metabolic signaling. Tesamorelin acts through the growth hormone-releasing hormone pathway and has an FDA-approved indication for reducing excess abdominal fat in a specific population.

Understanding these differences is important when considering peptide therapy.

What Is AOD-9604?

AOD-9604 is a modified fragment derived from a portion of human growth hormone.

It was developed to investigate whether some of growth hormone’s metabolic effects could potentially be separated from its broader growth-promoting effects.

This made AOD-9604 particularly interesting to researchers studying fat metabolism and obesity.

How Does AOD-9604 Work?

AOD-9604 has been investigated for its potential influence on lipid and fat-metabolism pathways.

Unlike full growth hormone, AOD-9604 was designed to avoid producing the same degree of growth-promoting activity associated with the complete GH molecule.

For this reason, you may see AOD-9604 discussed in connection with:

  • Fat metabolism
  • Lipolysis research
  • Body composition
  • Metabolic health

However, there is an important distinction between a proposed mechanism and proven clinical weight loss.

What Is MOTS-c?

  1. MOTS-c is very different from AOD-9604.

    It is a mitochondrial-derived peptide, meaning it originates from genetic information within the mitochondria rather than functioning primarily through the traditional growth hormone pathway.

    Mitochondria are responsible for producing much of the energy our cells require.

    That makes MOTS-c especially interesting in research involving:

    • Cellular energy
    • Glucose metabolism
    • Insulin sensitivity
    • Metabolic flexibility
    • Exercise physiology
    • Healthy aging

How Does MOTS-c Work?

Research suggests MOTS-c participates in signaling pathways that help cells respond to metabolic stress and regulate energy utilization.

One pathway frequently studied in connection with MOTS-c is AMP-activated protein kinase, or AMPK.

AMPK functions somewhat like a cellular energy sensor.

When cellular energy availability changes, AMPK helps regulate processes involving glucose utilization, fatty-acid metabolism, and energy production.

This is why MOTS-c has generated considerable interest in metabolic and longevity research.

However, MOTS-c remains investigational. Human evidence is substantially more limited than the evidence available for established FDA-approved metabolic medications.

Ready for a More Personalized Approach?

If you’re exploring GLP-1 therapy and want a more tailored, sustainable strategy, New Life Heal offers individualized metabolic and hormone optimization programs designed around your body—not a protocol template.

Because the goal isn’t just weight loss—it’s long-term metabolic health.

**The information provided in this article is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. It should not be used as a substitute for consultation with a qualified healthcare provider.

All medical treatments, including tirzepatide and any related dosing strategies (including off-label or “microdosing” approaches), should only be used under the supervision of a licensed medical professional.